AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 191 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $716,000 | -94.9% | 52,724 | -96.9% | 0.01% | -97.0% |
| Q1 2019 | $13,951,000 | +51.9% | 1,703,440 | 0.0% | 0.39% | +12.9% |
| Q4 2018 | $9,182,000 | -57.5% | 1,703,440 | -30.5% | 0.35% | -39.6% |
| Q3 2018 | $21,629,000 | -2.2% | 2,449,521 | +10.6% | 0.58% | -0.3% |
| Q2 2018 | $22,110,000 | -5.8% | 2,215,400 | -10.0% | 0.58% | -11.7% |
| Q1 2018 | $23,467,000 | -20.6% | 2,462,400 | +23.9% | 0.66% | -33.0% |
| Q4 2017 | $29,553,000 | -53.9% | 1,987,400 | -39.0% | 0.98% | -19.9% |
| Q3 2017 | $64,124,000 | +305.6% | 3,260,000 | +196.4% | 1.22% | +54.0% |
| Q2 2017 | $15,808,000 | +3359.1% | 1,100,000 | +2116.7% | 0.80% | +2957.7% |
| Q1 2017 | $457,000 | -91.8% | 49,624 | -90.8% | 0.03% | -93.5% |
| Q4 2016 | $5,593,000 | -23.3% | 537,256 | -33.6% | 0.40% | -15.5% |
| Q3 2016 | $7,295,000 | +9.1% | 809,096 | -9.5% | 0.47% | +1.7% |
| Q2 2016 | $6,684,000 | -14.2% | 893,600 | +3.3% | 0.46% | -32.3% |
| Q1 2016 | $7,794,000 | +132.0% | 865,000 | +232.7% | 0.68% | +174.7% |
| Q4 2015 | $3,359,000 | -33.1% | 260,000 | -50.0% | 0.25% | +23.9% |
| Q3 2015 | $5,024,000 | – | 520,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |